LBRX · Lb Pharmaceuticals Inc
Market Cap
$1.51B
Shares
32.26M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Coverage backlog: 9 eligible filings and 0 covenant artifacts have no current-version terminal extraction result. This includes untouched sources and sources on the retry ladder.
No terminal debt extraction result is available yet; this is not evidence that the company has no debt.
Key facts
CIK
1691082
CUSIP
50180M108
13F (30d)
99 filings
99 filers
Visit website
Investor relations